Investor profile
Portfolio Ventures
Angel syndicate
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Portfolio Ventures is a London-based institutional angel fund investing £100k–£500k cheques into UK-based Fintech, Insurtech, B2B SaaS, and Enterprise Software companies from Pre-Seed to Series A. Founded in 2014 by Will Martin and Will Brooks, the firm aims to be the co-investor of choice for UK founders and VCs — an 'institutional angel' that every founder wants on their cap table, leveraging a large LP community of 300+ angels, founders, and GPs alongside an extensive investor and founder network to provide strategic support as portfolio companies scale.
Notable quotes
“We are delighted to have closed our 2nd Angel Fund as we continue to invest and support some of the U.K.'s leading entrepreneurs as they scale. PV has always been about network and accessibility.”
“Our strategy is to build a highly diversified portfolio of early-stage tech companies, following lead VCs, investing multi-stage (pre-seed to A) and multi-sector (primarily focused on fintech and SaaS).”
“Our vision is to be the co-investor of choice, an 'institutional angel' that every founder wants on their cap table.”
Team
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Paypercut | Seed | $3m | 2026-06-03 |
| Overmind | Seed | $3m | 2026-02-11 |
| Conveyd | Seed | $3m | 2025-12-12 |
| Kohort | Series A | — | 2025-06-05 |
| Bit Fount | Series A | $8m | 2025-07-23 |
| Marshmallow | Series B | $85m | — |
| Tractable | Seed | — | — |
| PensionBee | Seed | — | — |
| Credit Kudos | Seed | — | — |
| Ably | Seed | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Playfair Capital | 4 |
| Hoxton Ventures | 3 |
| First Minute Capital | 3 |
| Episode 1 Ventures | 2 |
| Eka Ventures | 2 |
| Passion Capital | 2 |
Fit check
Is Portfolio Ventures a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit